Agilent Technologies, Inc. $A Shares Acquired by State of New Jersey Common Pension Fund D

State of New Jersey Common Pension Fund D grew its position in shares of Agilent Technologies, Inc. (NYSE:A) by 5.8% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 98,873 shares of the medical research company’s stock after purchasing an additional 5,411 shares during the quarter. State of New Jersey Common Pension Fund D’s holdings in Agilent Technologies were worth $12,690,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. Brighton Jones LLC increased its holdings in Agilent Technologies by 6.1% in the fourth quarter. Brighton Jones LLC now owns 4,663 shares of the medical research company’s stock valued at $626,000 after buying an additional 270 shares in the last quarter. Jones Financial Companies Lllp grew its position in shares of Agilent Technologies by 15.9% during the 1st quarter. Jones Financial Companies Lllp now owns 5,610 shares of the medical research company’s stock valued at $602,000 after acquiring an additional 769 shares during the period. Geneos Wealth Management Inc. increased its stake in shares of Agilent Technologies by 54.8% in the 1st quarter. Geneos Wealth Management Inc. now owns 599 shares of the medical research company’s stock valued at $70,000 after purchasing an additional 212 shares in the last quarter. Acadian Asset Management LLC raised its holdings in Agilent Technologies by 16.5% in the 1st quarter. Acadian Asset Management LLC now owns 5,352 shares of the medical research company’s stock worth $625,000 after purchasing an additional 758 shares during the period. Finally, Sivia Capital Partners LLC acquired a new position in Agilent Technologies in the 2nd quarter worth about $273,000.

Insider Activity

In related news, VP Rodney Gonsalves sold 3,000 shares of Agilent Technologies stock in a transaction that occurred on Wednesday, November 26th. The stock was sold at an average price of $154.99, for a total transaction of $464,970.00. Following the transaction, the vice president owned 31,846 shares in the company, valued at approximately $4,935,811.54. This trade represents a 8.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link.

Agilent Technologies Trading Up 0.7%

Shares of A opened at $125.80 on Tuesday. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $160.27. The stock has a market cap of $35.58 billion, a PE ratio of 27.53, a price-to-earnings-growth ratio of 3.65 and a beta of 1.30. The firm’s fifty day moving average is $137.51 and its two-hundred day moving average is $135.61. The company has a quick ratio of 1.52, a current ratio of 1.96 and a debt-to-equity ratio of 0.45.

Agilent Technologies (NYSE:A) last posted its quarterly earnings results on Monday, November 24th. The medical research company reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.58 by $0.01. The firm had revenue of $1.86 billion for the quarter, compared to the consensus estimate of $1.83 billion. Agilent Technologies had a net margin of 18.75% and a return on equity of 25.20%. The company’s revenue for the quarter was up 9.4% on a year-over-year basis. During the same period last year, the firm posted $1.46 earnings per share. Agilent Technologies has set its Q1 2026 guidance at 1.350-1.380 EPS and its FY 2026 guidance at 5.860-6.000 EPS. Research analysts forecast that Agilent Technologies, Inc. will post 5.58 earnings per share for the current fiscal year.

Agilent Technologies Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, April 22nd. Stockholders of record on Tuesday, March 31st will be issued a dividend of $0.255 per share. This represents a $1.02 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Tuesday, March 31st. Agilent Technologies’s payout ratio is currently 22.32%.

Wall Street Analysts Forecast Growth

Several analysts have commented on A shares. The Goldman Sachs Group started coverage on Agilent Technologies in a report on Tuesday, December 9th. They issued a “buy” rating and a $170.00 price objective on the stock. Robert W. Baird lifted their price target on shares of Agilent Technologies from $142.00 to $165.00 and gave the company an “outperform” rating in a research note on Tuesday, November 25th. HSBC assumed coverage on shares of Agilent Technologies in a research report on Tuesday, January 20th. They set a “buy” rating and a $180.00 price objective for the company. UBS Group lifted their target price on shares of Agilent Technologies from $170.00 to $180.00 and gave the company a “buy” rating in a research report on Tuesday, November 25th. Finally, Weiss Ratings reissued a “hold (c+)” rating on shares of Agilent Technologies in a research note on Monday, December 29th. Two research analysts have rated the stock with a Strong Buy rating, eleven have given a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $164.50.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.